The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Biogen, Inc. Investors

BENSALEM, Pa.--(BUSINESS WIRE)--

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors of Biogen, Inc. ("Biogen" or the "Company") BIIB who purchased shares between January 29, 2015 and July 23, 2015, inclusive (the "Class Period") and have been damaged by the recent declines in the Company's stock price. Biogen investors have until October 19, 2015 to file a lead plaintiff motion. Investors with losses of over $500,000 are encouraged to contact Howard G. Smith, Esq. to discuss their legal rights.

Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. On July 24, 2015 Biogen announced Second Quarter 2015 results and updated its full-year financial guidance decreasing revenue growth to 6% to 8% based largely on revised expectations for the growth of multiple-sclerosis drug tecfidera. The Company announced that sales of tecfidera have slowed on safety concerns following last year's report of the death of a tecfidera patient. On this news, Biogen shares dropped as much as $74.34, or 19.31%, during intraday trading on July 24, 2015, thereby damaging investors.

If you purchased shares of Biogen during the Class Period, you may move the Court no later than October 19, 2015 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151013006391/en/